Heather P. Llewellyn

Heather P. Llewellyn

Auto-generated profile, based on publicly available information

Heather P. Llewellyn

Global Biomarkers, Drug Safety Research and Development (DSRD), La Jolla, CA, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2017 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
HPHeather M. Perry
Heather M. Perry
LHLiping Huang
Liping Huang
RWRebecca J. Wilson
Rebecca J. Wilson
ABAmandeep Bajwa
Amandeep Bajwa
HSHiromi Sesaki
Hiromi Sesaki
MOMark D. Okusa
Mark D. Okusa
The proximal tubule epithelium relies on mitochondrial function for energy, rendering the kidney highly susceptible to ischemic AKI. Dynamin-related protein 1 (DRP1), a mediator of mitochondrial fission, regulates mitochondrial function; however, the cell-specific and temporal role of DRP1 in AKI in vivo is unknown. Using genetic murine models, we found that proximal tubule–specific deletion of Drp1 prevented the renal ischemia-reperfusion–induced kidney injury, inflammation, and programmed cell death observed in wild-type mice and promoted epithelial recovery, which associated with activation of the renoprotective β-hydroxybutyrate signaling pathway. Loss of DRP1 preserved mitochondrial structure and reduced oxidative stress in injured kidneys. Lastly, proximal tubule deletion of DRP1 after ischemia-reperfusion injury attenuated progressive kidney injury and fibrosis. These results implicate DRP1 and mitochondrial dynamics as an important mediator of AKI and progression to fibrosis and suggest that DRP1 may serve as a therapeutic target for AKI.

4 June 2018 in Journal of the American Society of Nephrology
Verified
Journal Article
Open access
PDF file
JJJakub Jankowski
Jakub Jankowski
HPHeather M. Perry
Heather M. Perry
CMChristopher B. Medina
Christopher B. Medina
LHLiping Huang
Liping Huang
JYJunlan Yao
Junlan Yao
MOMark D. Okusa
Mark D. Okusa
BackgroundPannexin1 (Panx1), an ATP release channel, is present in most mammalian tissues, but the role of Panx1 in health and disease is not fully understood. Panx1 may serve to modulate AKI; ATP is a precursor to adenosine and may function to block inflammation, or ATP may act as a danger-associated molecular pattern and initiate inflammation.MethodsWe used pharmacologic and genetic approaches to evaluate the effect of Panx1 on kidney ischemia-reperfusion injury (IRI), a mouse model of AKI.ResultsPharmacologic inhibition of gap junctions, including Panx1, by administration of carbenoxolone protected mice from IRI. Furthermore, global deletion ofPanx1preserved kidney function and morphology and diminished the expression of proinflammatory molecules after IRI. Analysis of bone marrow chimeric mice revealed that Panx1 expressed on parenchymal cells is necessary for ischemic injury, and both proximal tubule and vascular endothelialPanx1tissue-specific knockout mice were protected from IRI.In vitro,Panx1-deficient proximal tubule cells released less and retained more ATP under hypoxic stress.ConclusionsPanx1 is involved in regulating ATP release from hypoxic cells, and reducing this ATP release may protect kidneys from AKI.

1 November 2021 in Journal of Hepatology
Verified
Journal Article
Closed access
HLHeather P. Llewellyn
Heather P. Llewellyn
SASeda Arat
Seda Arat
JGJingjin Gao
Jingjin Gao
JWJi Wen
Ji Wen
SXShuhua Xia
Shuhua Xia
CJChanghua Ji
Changhua Ji

23 January 2021 in Toxicological Sciences
Verified
Journal Article
Open access
PDF file
HLHeather P Llewellyn
Heather P Llewellyn
VVVishal S Vaidya
Vishal S Vaidya
ZWZhenyu Wang
Zhenyu Wang
QPQinghai Peng
Qinghai Peng
CHCraig Hyde
Craig Hyde
SRShashi K Ramaiah
Shashi K Ramaiah
Early diagnosis of drug-induced liver injury (DILI) continues to be a major hurdle during drug development and postmarketing. The objective of this study was to evaluate the diagnostic performance of promising biomarkers of liver injury—glutamate dehydrogenase (GLDH), cytokeratin-18 (K18), caspase-cleaved K18 (ccK18), osteopontin (OPN), macrophage colony-stimulating factor (MCSF), MCSF receptor (MCSFR), and microRNA-122 (miR-122) in comparison to the traditional biomarker alanine aminotransferase (ALT). Biomarkers were evaluated individually and as a multivariate model in a cohort of acetaminophen overdose (n = 175) subjects and were further tested in cohorts of healthy adults (n = 135), patients with liver damage from various causes (n = 104), and patients with damage to the muscle (n = 74), kidney (n = 40), gastrointestinal tract (n = 37), and pancreas (n = 34). In the acetaminophen cohort, a multivariate model with GLDH, K18, and miR-122 was able to detect DILI more accurately than individual biomarkers alone. Furthermore, the three-biomarker model could accurately predict patients with liver injury compared with healthy volunteers or patients with damage to muscle, pancreas, gastrointestinal tract, and kidney. Expression of K18, GLDH, and miR-122 was evaluated using a database of transcriptomic profiles across multiple tissues/organs in humans and rats. K18 mRNA (Krt18) and MiR-122 were highly expressed in liver whereas GLDH mRNA (Glud1) was widely expressed. We performed a comprehensive, comparative performance assessment of 7 promising biomarkers and demonstrated that a 3-biomarker multivariate model can accurately detect liver injury.